<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/340288BD-BCA1-46AA-BA5C-D85DDA0D29C8"><gtr:id>340288BD-BCA1-46AA-BA5C-D85DDA0D29C8</gtr:id><gtr:name>August Pi i Sunyer Biomedical Research Institute (IDIBAPS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CA59D75D-1AD9-4235-8F35-4E7E6E68EB81"><gtr:id>CA59D75D-1AD9-4235-8F35-4E7E6E68EB81</gtr:id><gtr:name>Norwegian University of Science and Technology (NTNU)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4E682F0C-74B5-4907-891D-7BAC440B9540"><gtr:id>4E682F0C-74B5-4907-891D-7BAC440B9540</gtr:id><gtr:name>University of Georgia</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/257C5108-1625-44DA-8C36-1FBC1CEF564E"><gtr:id>257C5108-1625-44DA-8C36-1FBC1CEF564E</gtr:id><gtr:name>King's College Hospital Charitable Trust</gtr:name><gtr:address><gtr:line1>King's College Hospital</gtr:line1><gtr:line2>Denamark Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SE8 9RS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/690ECCF2-F290-4AE0-82CC-F5507E8EDC7E"><gtr:id>690ECCF2-F290-4AE0-82CC-F5507E8EDC7E</gtr:id><gtr:name>Agency for Science, Technology and Research (A*STAR)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1F10FB6B-C9C3-4B3B-A91B-AF695129C094"><gtr:id>1F10FB6B-C9C3-4B3B-A91B-AF695129C094</gtr:id><gtr:name>University of Liege</gtr:name><gtr:address><gtr:line1>Place du 20-Aout, 7</gtr:line1><gtr:line4>Liege</gtr:line4><gtr:line5>B-4000</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/22748C58-39CF-4110-8F6C-B0D1D5DF85F3"><gtr:id>22748C58-39CF-4110-8F6C-B0D1D5DF85F3</gtr:id><gtr:name>?cole normale sup?rieure de Lyon (ENS Lyon)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Surgery</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/340288BD-BCA1-46AA-BA5C-D85DDA0D29C8"><gtr:id>340288BD-BCA1-46AA-BA5C-D85DDA0D29C8</gtr:id><gtr:name>August Pi i Sunyer Biomedical Research Institute (IDIBAPS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CA59D75D-1AD9-4235-8F35-4E7E6E68EB81"><gtr:id>CA59D75D-1AD9-4235-8F35-4E7E6E68EB81</gtr:id><gtr:name>Norwegian University of Science and Technology (NTNU)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4E682F0C-74B5-4907-891D-7BAC440B9540"><gtr:id>4E682F0C-74B5-4907-891D-7BAC440B9540</gtr:id><gtr:name>University of Georgia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/257C5108-1625-44DA-8C36-1FBC1CEF564E"><gtr:id>257C5108-1625-44DA-8C36-1FBC1CEF564E</gtr:id><gtr:name>King's College Hospital Charitable Trust</gtr:name><gtr:address><gtr:line1>King's College Hospital</gtr:line1><gtr:line2>Denamark Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SE8 9RS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/690ECCF2-F290-4AE0-82CC-F5507E8EDC7E"><gtr:id>690ECCF2-F290-4AE0-82CC-F5507E8EDC7E</gtr:id><gtr:name>Agency for Science, Technology and Research (A*STAR)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1F10FB6B-C9C3-4B3B-A91B-AF695129C094"><gtr:id>1F10FB6B-C9C3-4B3B-A91B-AF695129C094</gtr:id><gtr:name>University of Liege</gtr:name><gtr:address><gtr:line1>Place du 20-Aout, 7</gtr:line1><gtr:line4>Liege</gtr:line4><gtr:line5>B-4000</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/22748C58-39CF-4110-8F6C-B0D1D5DF85F3"><gtr:id>22748C58-39CF-4110-8F6C-B0D1D5DF85F3</gtr:id><gtr:name>?cole normale sup?rieure de Lyon (ENS Lyon)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/19564F2D-FB00-4F3E-B119-57D7A97648B8"><gtr:id>19564F2D-FB00-4F3E-B119-57D7A97648B8</gtr:id><gtr:firstName>Stefano</gtr:firstName><gtr:surname>Pluchino</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C04DE242-FC3C-4D5A-B576-037A94215D60"><gtr:id>C04DE242-FC3C-4D5A-B576-037A94215D60</gtr:id><gtr:firstName>Ludovic</gtr:firstName><gtr:surname>Vallier</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0701448"><gtr:id>073ACFB5-E043-4211-9FBD-1A1F32910732</gtr:id><gtr:title>Molecular mechanisms controlling differentiation of pluripotent cells into endoderm.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0701448</gtr:grantReference><gtr:abstractText>During the last decade various stem cells have been derived from adult or embryonic human tissues. These cells offer new prospects to treat degenerative diseases, since they can specialise into many mature cell types that could be useful for cell based therapies. However, robust protocols allowing the production of fully functional specialised cells still need to be established. The generation of such cell types may ultimately only be achievable by recapitulating a normal path of development in vitro. But the sequential events leading to the formation of the primary germ layers, the building block of the body?s organs, remain obscure. Thus, the understanding of the mechanisms controlling the specification of the primary germ layers has a major importance for regenerative medicine. Here, I propose to use human Embryonic Stem cells (hESCs) to study the mechanisms controlling differentiation of the endoderm germ layer, from which originate the pancreas, liver, lungs, and gut. While the objective of this project is to control differentiation of hESCs into endoderm lineages, the insight that will be gained could also be used to convert adult cells to endodermal cells by recapitulating the developmental pathway that forms this tissue during normal development.</gtr:abstractText><gtr:technicalSummary>Generation of all the adult tissues occurs by progressive cell fate decisions, starting with the specification of the three primary germ layers (ectoderm, mesoderm and endoderm). Molecular mechanisms controlling specification of the germ layers have been extensively studied in amphibia and fish. However, the understanding of these mechanisms in mammals (especially humans) is more limited, and this represents a major drawback for regenerative medicine. Indeed the generation of fully functional cell types from stem cells may only be achievable by recapitulating a normal species specific succession of cell fate decisions. 
The studies of these mechanisms at the molecular level in vivo are restricted in mammals and particularly in humans, by the difficulty of obtaining sufficient biological material. The recent availability of human Embryonic Stem cells (hESCs) offers new possibilities to resolve this major limitation. Their embryonic origin confers upon them the ability to proliferate indefinitely in vitro while maintaining the capacity to differentiate into extra-embryonic tissues and into derivatives of the three primary germ layers. Here, I propose to define the network of transcription factors controlling differentiation of pluripotent cells into endoderm using first hESCs as an in vitro model of human development and then using mouse embryos to validate these results in vivo.
This project will be based on functional studies and on high throughput approaches including chromatin immunoprecipitation (ChIP) assays and gene expression profiling. Importantly, differentiation of hESCs into definitive endoderm cells will be achieved using fully chemically defined culture conditions which are devoid of animal products, thereby eliminating factors that could obscure analysis of developmental mechanisms or render the resulting tissues incompatible with future clinical applications. This method of differentiation has been developed during my current fellowship and the endoderm progenitors generated have been extensively characterised by both molecular analytical and cellular functional assays. 
In summary, the objectives of this proposal are (i) to identify the key transcription factors controlling endoderm differentiation and to define precisely their function, (ii) to reveal the organisation of the core transcriptional network controlling the expression of these transcription factors during the transition between the pluripotent state and the endoderm fate and (iii) to define the downstream network of genes controlled by these transcription factors. The overall outcome of this project will gain the knowledge needed to control differentiation of hESCs into specific lineages and also potentially to enable trans-differentiation of other cell types, including adult stem cells and adult somatic cells.</gtr:technicalSummary><gtr:fund><gtr:end>2013-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1447565</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Norwegian University of Science and Technology (NTNU)</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:department>Department of Cancer Research and Molecular Medicine (IKM)</gtr:department><gtr:description>Encapsulation of pancreatic cells</gtr:description><gtr:id>6EFD268B-8D62-4D70-9BD6-B0538CF08CDD</gtr:id><gtr:impact>Eu grant application plus training and visit. 1 publication</gtr:impact><gtr:outcomeId>dSf9ctJj31b-1</gtr:outcomeId><gtr:partnerContribution>Eu grant application + complementary expertise</gtr:partnerContribution><gtr:piContribution>The main goal is to encapsulate pancretaic cells from hESCs or hIPSCs and to define the functionality of the resulting cells in animal model</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Gene knock out in hPSCs</gtr:description><gtr:id>D4B8258B-20B5-4E57-8630-A16E99DD5EE0</gtr:id><gtr:impact>None the collaboration was stopped due to technical difficulties</gtr:impact><gtr:outcomeId>mpxyX8jR2im-1</gtr:outcomeId><gtr:partnerContribution>Provide and design TALENS</gtr:partnerContribution><gtr:piContribution>Perform gene targeting in hPSCs using TALENs provided by collaborator</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Liege</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>hESCs and training</gtr:description><gtr:id>E45D4FF9-0F04-460A-90DA-9A4EB5685BFD</gtr:id><gtr:impact>We have provided training to grow hESCs and exchanging idead/information on a regular basis.</gtr:impact><gtr:outcomeId>137DAE2F7E7-1</gtr:outcomeId><gtr:partnerContribution>None</gtr:partnerContribution><gtr:piContribution>The mainobjective of this collaboration is to use hESCs as in vitro model of neuronal development.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>August Pi i Sunyer Biomedical Research Institute (IDIBAPS)</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Endocrinology Unit</gtr:department><gtr:description>Epigenetic status of pancreatic progenitors generated from hESCs</gtr:description><gtr:id>79FD4679-7B79-4288-8ADE-7B48D57B11BB</gtr:id><gtr:impact>1 Publication and EU grant application have been submitted.</gtr:impact><gtr:outcomeId>FjCWKW5Wm4t-1</gtr:outcomeId><gtr:partnerContribution>Complementary expertise and network collaboratorsComplemtenary expertise and future grant applications</gtr:partnerContribution><gtr:piContribution>We have provided pancreatic progenitors generated from hIPSCs/hESCs</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Georgia</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>hPSCs and cell cycle</gtr:description><gtr:id>27C90E1D-CC05-41EE-AF57-37197ECFD0E7</gtr:id><gtr:impact>publications in preparation</gtr:impact><gtr:outcomeId>pHGykZr5bv4-1</gtr:outcomeId><gtr:partnerContribution>exchange of data and reagents</gtr:partnerContribution><gtr:piContribution>exchange of data and reagents</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Epigenetic status of pancreatic progenitors generated from hESCs</gtr:description><gtr:id>917FC108-DD84-42E2-AC2E-5473B9CB29BE</gtr:id><gtr:impact>1 Publication and EU grant application have been submitted.</gtr:impact><gtr:outcomeId>FjCWKW5Wm4t-2</gtr:outcomeId><gtr:partnerContribution>Complementary expertise and network collaboratorsComplemtenary expertise and future grant applications</gtr:partnerContribution><gtr:piContribution>We have provided pancreatic progenitors generated from hIPSCs/hESCs</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>In vivo validation of hIPSCs-hep</gtr:description><gtr:id>06B9C2AB-831C-437D-8DFA-63ECA520ABF1</gtr:id><gtr:impact>Unique expertise and animal models. Grant applications and publication</gtr:impact><gtr:outcomeId>HcDCvGPdpHi-1</gtr:outcomeId><gtr:partnerContribution>Animal model</gtr:partnerContribution><gtr:piContribution>In vivo validation of hIPSCs derived hepatocytes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>?cole normale sup?rieure de Lyon (ENS Lyon)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>INSERM U846 (Stem-cell and Brain Research Institute)</gtr:department><gtr:description>In vivo validation of IPSC derived hepatocytes</gtr:description><gtr:id>D7919476-F1AC-4006-90E3-67AEE70BC738</gtr:id><gtr:impact>Publication + Grant application</gtr:impact><gtr:outcomeId>LF5Caeb7M13-1</gtr:outcomeId><gtr:partnerContribution>Animal model + grant applications</gtr:partnerContribution><gtr:piContribution>Test capacity of hIPSC derived hepatocytes to colonise the liver of mouse model for liver failure</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Mesoderm differentiation</gtr:description><gtr:id>263FC422-D6E9-4845-A065-75BBFA6BE35D</gtr:id><gtr:impact>We have obatined several MRC grant and we ahve been co-author on a lrge number of publications</gtr:impact><gtr:outcomeId>05405BA20F0-1</gtr:outcomeId><gtr:partnerContribution>We have written several publications and applied for several grant.</gtr:partnerContribution><gtr:piContribution>Our main objective is to study human pluripotent stem cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Agency for Science, Technology and Research (A*STAR)</gtr:collaboratingOrganisation><gtr:country>Singapore, Republic of</gtr:country><gtr:department>Genome Institute of Singapore</gtr:department><gtr:description>Endoderm Differentiation 3</gtr:description><gtr:id>9DB3F5A3-4519-47F7-888F-3B948CA628A3</gtr:id><gtr:impact>We have published one publication and two others are in preparation.</gtr:impact><gtr:outcomeId>B0C8D2A1843-1</gtr:outcomeId><gtr:partnerContribution>We co-supervise a PhD a ASTAR PhD student</gtr:partnerContribution><gtr:piContribution>Our obejctive is to study the mechanisms controlling endoderm differentiation.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Health and Medical Research (INSERM)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Hopital Bicetre</gtr:department><gtr:description>Generation of hepatocyte</gtr:description><gtr:id>1489585F-A0FB-4CC9-ADAB-709A9C8D3F41</gtr:id><gtr:impact>We have published 3 papers and obtained one EU-Grant Liv-ES PubMEDID: 19564924 1968839 Touboul et al., in press in Hepatology</gtr:impact><gtr:outcomeId>7B69E0C6A65-1</gtr:outcomeId><gtr:partnerContribution>We have published 3 manuscripts and applied for several grant including a sucessful EU grant.</gtr:partnerContribution><gtr:piContribution>Weare developing protocols to generate liver cells from human plurioptent stem cells</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Pluripotency and Cancer</gtr:description><gtr:id>D1FE7D41-CB32-4C2F-B76E-B522AEC0CB0E</gtr:id><gtr:impact>We have published one paper in collaboration and also applied for a grant. Pub Med ID:19688839</gtr:impact><gtr:outcomeId>3218FD5FD29-1</gtr:outcomeId><gtr:partnerContribution>provide expertise on teratoma formation and perform experiments</gtr:partnerContribution><gtr:piContribution>Our main objective is to use human pluripotent stem cells to study cancer.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Aberdeen</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Life Sciences and Medicine</gtr:department><gtr:description>Differentiation of Pancreatic cells</gtr:description><gtr:id>71F7F912-6D60-4A08-A545-2359D665D6E4</gtr:id><gtr:impact>We published two artciles and applied successfully to several grants. PubMedID 19056911 17959396</gtr:impact><gtr:outcomeId>47F6DCE4D74-1</gtr:outcomeId><gtr:partnerContribution>We published two publications and we have applied for several grants</gtr:partnerContribution><gtr:piContribution>We are currently developing protocol to generate pancreatic cells from human pluripotent stem cells for clinical applications.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College Hospital NHS Foundation Trust (NCH)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Paediatric Liver Centre</gtr:department><gtr:description>hIPSC differentiation into Cholangyocites</gtr:description><gtr:id>5F4B7E5A-927D-4CCD-92DE-E7813EA651C3</gtr:id><gtr:impact>This collaboration has resulted in a successful application to a MRC clinical PhD fellowship and in 1 publication</gtr:impact><gtr:outcomeId>538520c6674ad6.48910322-1</gtr:outcomeId><gtr:partnerContribution>Access to patients</gtr:partnerContribution><gtr:piContribution>Bring expertise in hIPSC and protocol of differentiation toward cholangyocite</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cardiovascular diseases</gtr:description><gtr:id>0F807057-4F87-4254-A6B5-6D1ED3117DE7</gtr:id><gtr:impact>My group was involved in a grant application related to this project and we are planning to train several collaborators.</gtr:impact><gtr:outcomeId>8CAFC43B089-1</gtr:outcomeId><gtr:partnerContribution>Expertise in disease model and sharing reagents</gtr:partnerContribution><gtr:piContribution>Our objective is to generate hIPSCs from patient with cardio-vascular disorders</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Structural Molecular Biology</gtr:department><gtr:description>Genetic of metabolic disoders</gtr:description><gtr:id>09F3F892-E80C-4469-B270-5C53FA7C246B</gtr:id><gtr:impact>Grant applications</gtr:impact><gtr:outcomeId>qboFiC9dAG5-1</gtr:outcomeId><gtr:partnerContribution>Access to patients and disease expertise</gtr:partnerContribution><gtr:piContribution>Develop in vitro model of metabolic diseases especially affecting the liver</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>hIPSCs and Epigenetic</gtr:description><gtr:id>4D658464-B229-4E97-8FE7-ECA96D07007E</gtr:id><gtr:impact>Two publications are curentrly in preparation and we obatined a grant from the TSB to continue this work.</gtr:impact><gtr:outcomeId>0713CB9DD79-1</gtr:outcomeId><gtr:partnerContribution>Develop new approach to characterise hIPSCs</gtr:partnerContribution><gtr:piContribution>The main objective of this colaboration is to define epigenetic variability among human induced pluripotent stem cells lines.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Press release BHF EPC paper</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BFD25EBD-1228-4A6A-B3BB-EC55C024D540</gtr:id><gtr:impact>No information available yet</gtr:impact><gtr:outcomeId>X8nYm396kfk</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Diverse New letters of patient group</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6C35651E-7BAE-42FA-9B98-1A8510D18357</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>JX8gdq3Rz6y</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Db UK / JDRF day in Cambridge</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7BBAC2FF-B56F-4E5E-94B0-09F1EC992FD9</gtr:id><gtr:impact>Discussion panel concerning future therapy of diabetes

None</gtr:impact><gtr:outcomeId>7EEA224A7A8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Night in the museum</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5FFBD51E-CF3D-4E8B-B41E-67B4AD892109</gtr:id><gtr:impact>around 100 people came to see the talk.

NA</gtr:impact><gtr:outcomeId>RGKEu5NFHmS</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url> http://www.bhf.org.uk/media/news-from-the-bhf/bhf-at-the-science-museum.aspx</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>2FE73DC3-6BE5-4E6D-A88D-E511B44C8205</gtr:id><gtr:impact>80 person attended to the talk and the following discussion.

Very goof feedback from patients group.</gtr:impact><gtr:outcomeId>cFfz7DP83ED</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>House of lord enquiry on regenerative medicine</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4B21143B-0852-4B84-AEB3-FEB1F41482DF</gtr:id><gtr:impact>NA / too soon

NA/ too soon</gtr:impact><gtr:outcomeId>ZCnwujFF96b</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BHF fund rising Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>21039F3C-2954-449A-A411-DB94C8C04318</gtr:id><gtr:impact>30 potential fund raisers

NA</gtr:impact><gtr:outcomeId>XJA8BxemL85</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url> http://www.bhf.org.uk/media/news-from-the-bhf/bhf-at-the-science-museum.aspx</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release Nature publication</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6DC48835-5804-451D-B83D-6CAFBAFC657F</gtr:id><gtr:impact>We had two press release (2010 and 2011) which resulted in more than 200 comments on radio, TV, web site, journals magazine, etc world wide

Very good return from the public and the stem cells field in general</gtr:impact><gtr:outcomeId>e4Y7E9eR5TQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010,2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>12500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC/Wellcome Trust Strategic award</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>7FE54666-1489-4F7B-890E-4230754892B1</gtr:id><gtr:outcomeId>m7cHWYj3hgE</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>145366</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Evelyn Trust - In vitro modelling of lung diseases using human Induced Pluripotent Stem Cells</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>The Evelyn Trust</gtr:fundingOrg><gtr:id>77DBDE88-D1B0-429A-A907-F36264DBF905</gtr:id><gtr:outcomeId>V8utLu1m7p40</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>450000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Innovative strategies to generate human hepatocytes for treatment of metabolic liver diseases: tolls for personalized cell therapy.</gtr:description><gtr:end>2014-11-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>0A7490D4-4472-4D0A-A26F-32BD9887ABA5</gtr:id><gtr:outcomeId>C8FWCa5YzUH0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>656986</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Manufacturing Solution for high value Induced pluripotent stem cells product</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Technology Strategy Board (TSB)</gtr:fundingOrg><gtr:id>8211D119-6783-4B63-A812-A38F3F687D98</gtr:id><gtr:outcomeId>D1BCE925B490</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1373000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>European Research Council - Reprogramming cell identity to develop new therapies against Inherited Metabolic Disorders of the liver</gtr:description><gtr:end>2016-11-02</gtr:end><gtr:fundingOrg>European Research Council (ERC)</gtr:fundingOrg><gtr:id>835D0819-4CDD-44CA-A57A-93CFC4A6F4FD</gtr:id><gtr:outcomeId>ioNAiSwLAA20</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>180000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Liv-ES Development of culture conditions for the differentiation of hES cells into hepatocytes (3m euros across 7 participants)</gtr:description><gtr:end>2012-11-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>05047A09-FF54-4DCC-8B97-C797610C595B</gtr:id><gtr:outcomeId>1D1F21F9A790</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2008-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>570000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The production of a 3D human tissue disease platform to enable regenerative medicine therapy development</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>79E1286C-36A3-41E3-A57C-14F6A25FF3B0</gtr:id><gtr:outcomeId>rgMi9gu5v2U0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>derivation of foregut stem cells</gtr:description><gtr:grantRef>G0701448</gtr:grantRef><gtr:id>68C0E187-F804-4119-8147-3CA14A2143BE</gtr:id><gtr:impact>publications</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>k4qND2TqFsF</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>In Vitro Production of Foregut Stem Cells</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Chemically defined culture conditions to drive differentiation of pluripotent cells into primary germ layers and into extra-embryonic tissues</gtr:description><gtr:grantRef>G0701448</gtr:grantRef><gtr:id>7AF421A1-80C3-4FD3-98D4-D142A5FC43ED</gtr:id><gtr:impact>NA</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>PUTuXo7VJPu</gtr:outcomeId><gtr:patentId>00 09006</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Chemically defined culture conditions to drive differentiation of pluripotent cells into primary germ layers and into extra-embryonic tissues</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>defined culture conditions to generate hepatocytes from hIPSCs for disease modelling</gtr:description><gtr:grantRef>G0701448</gtr:grantRef><gtr:id>F406584D-A485-4FF5-9E54-209BB68F7BB9</gtr:id><gtr:impact>NA</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>L6uZkTjCTUg</gtr:outcomeId><gtr:patentId>WO2012025725</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>In vitro hepatic differentiation</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Cell-Cycle Directed Differentiation of Pluripotent Cells</gtr:description><gtr:grantRef>G0701448</gtr:grantRef><gtr:id>3ADA4C90-C419-4438-BEA1-AD859FB7C70D</gtr:id><gtr:impact>publication</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>WdVGGiTpKTc</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>Cell-Cycle Directed Differentiation of Pluripotent Cells</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>In Vitro Pancreatic Differentiation of Pluripotent Mammalian Cells</gtr:description><gtr:grantRef>G0701448</gtr:grantRef><gtr:id>BE7706D6-9059-4AC3-93D0-937D3FBCB9AD</gtr:id><gtr:impact>publications</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>DXM46PgdTVk</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>In Vitro Pancreatic Differentiation of Pluripotent Mammalian Cells</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Method to derive pluripotent cells from post-implantation stages</gtr:description><gtr:grantRef>G0701448</gtr:grantRef><gtr:id>2925F697-B43C-4ED5-9A59-06A7F0135A49</gtr:id><gtr:impact>NA</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>BCx4JmKFnSA</gtr:outcomeId><gtr:patentId>07824531.3</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Method to derive pluripotent cells from post-implantation stages</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Method for generating hIPSC from Endothelial Progenitor Cells.</gtr:description><gtr:grantRef>G0701448</gtr:grantRef><gtr:id>82CD3467-81C8-4B2C-BEFB-E664B39FDAC0</gtr:id><gtr:impact>NA</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>or9R8REL11e</gtr:outcomeId><gtr:patentId>WO2012131387</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>NUCLEAR REPROGRAMMING SUBSTRATE</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>International consortium large scale hIPSCs project</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>4A09E420-EE91-4709-81E7-331D8299D7AD</gtr:id><gtr:outcomeId>K5rTjaoi273</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Hepatocytes differentiated from hIPSC generated from patients with genetic disorders.</gtr:description><gtr:id>5C45B5B3-E3EC-4AD8-BD19-DE7A97AC8ABE</gtr:id><gtr:impact>Creation spin out DefiniGEN</gtr:impact><gtr:outcomeId>jNFNi95zouc</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Disease model for drug and toxicology  screening</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2011</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have identified a new type of endodermal stem cells.</gtr:description><gtr:id>9A35D0F3-327C-43CE-8ABD-02CECB34EDF1</gtr:id><gtr:impact>These cells could enable the production of homogenous population of pancreatic, lung, and hepatic cells from a broad number of hPSCs.</gtr:impact><gtr:outcomeId>FShUYUsydwN</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Foregut Stem Cells</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have derived a lrge number of hIPSCs lines from patients suffereing of diverse diseases</gtr:description><gtr:id>0675D910-953D-4375-A14D-CDE2E7025D52</gtr:id><gtr:impact>We hope to develop new in vitro of model disease for basic studies and drug screening.</gtr:impact><gtr:outcomeId>B2F7349F15C</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>hIPSCs lines from patient with metabolic diseases</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We sdeveloped a new culture system to differentiate human pluripotent stem cells into endoderm and then into pancreatic and hepatic cells.</gtr:description><gtr:id>1B9524DF-E72C-4E1C-8587-27EF90F763DB</gtr:id><gtr:impact>These cultures systems are fully defined and fully compatible with clinical applications</gtr:impact><gtr:outcomeId>418B5A6A6EF</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human endoderm cells and derivatives</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed a new protocol to generate pancreatic cells from hPSCs in defined conditions.</gtr:description><gtr:id>6F53EA17-B1A9-4E8D-8864-7CE45FA509A6</gtr:id><gtr:impact>Important new information regarding pancreatic development and future clinical applications</gtr:impact><gtr:outcomeId>MxUedRC4bkE</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Protocol to generate pancretaic cells from hPSCs</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We developed an new method to perform ChIP -seq on factor which does not bind DNA directly such as Smad2/3.</gtr:description><gtr:id>F4E14B84-48A0-4852-8D15-D50C081ABD6F</gtr:id><gtr:impact>This approach have allowed to map Smad2/3 binding sites at the genome wide level and is now currently used by a broad number of groups to perform similar studies on a diversity of transcription factors.</gtr:impact><gtr:outcomeId>5385221db82555.93283347</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>improve efficiency of Chromatin  IP</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>DefiniGEN</gtr:companyName><gtr:description>Definigen provides human liver cells for preclinical drug development and disease modelling applications using human Induced Pluripotent Stem Cell hIPSC technology.

http://www.definigen.com/</gtr:description><gtr:id>161CA486-ABC6-48DB-91B9-B80C5CF44354</gtr:id><gtr:impact>NA</gtr:impact><gtr:outcomeId>nVhvRxAQLeX</gtr:outcomeId><gtr:url>http://www.definigen.com/</gtr:url><gtr:yearCompanyFormed>2012</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>488699F5-91DD-41D8-B42F-89CA105B198A</gtr:id><gtr:title>Multiple roles of Activin/Nodal, bone morphogenetic protein, fibroblast growth factor and Wnt/?-catenin signalling in the anterior neural patterning of adherent human embryonic stem cell cultures.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de98e60228b2f89b7fca77d65ccdde70"><gtr:id>de98e60228b2f89b7fca77d65ccdde70</gtr:id><gtr:otherNames>Lupo G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>doi_12903_sob_120167</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE3BB92D-7A09-457C-BB8A-EFD818553C69</gtr:id><gtr:title>Interaction of Salmonella enterica Serovar Typhimurium with Intestinal Organoids Derived from Human Induced Pluripotent Stem Cells.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8681ee6fba773595d587c1f07dc6ba68"><gtr:id>8681ee6fba773595d587c1f07dc6ba68</gtr:id><gtr:otherNames>Forbester JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>56b98e2693aca3.63624441</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A245D33E-3AF4-4D63-843A-BE0453A989C8</gtr:id><gtr:title>A factor(s) secreted from MIN-6 beta-cells stimulates differentiation of definitive endoderm enriched embryonic stem cells towards a pancreatic lineage.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ba982cf43652b50aec9e5a61291d57f"><gtr:id>3ba982cf43652b50aec9e5a61291d57f</gtr:id><gtr:otherNames>Uroic DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn><gtr:outcomeId>epvDzya4hPz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5A459E9-0474-4BC7-B6D4-CB533A17D068</gtr:id><gtr:title>Targeted gene correction of a1-antitrypsin deficiency in induced pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be1bae898aea75410b34af4f816f8a7a"><gtr:id>be1bae898aea75410b34af4f816f8a7a</gtr:id><gtr:otherNames>Yusa K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>KB8ejgkDtwy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>641C45CF-2672-440D-855D-1EE6D41F71FA</gtr:id><gtr:title>Human pluripotent stem cells for modelling human liver diseases and cell therapy.</gtr:title><gtr:parentPublicationTitle>Current gene therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/633fc227e239623ea46332389250ef53"><gtr:id>633fc227e239623ea46332389250ef53</gtr:id><gtr:otherNames>Dianat N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1566-5232</gtr:issn><gtr:outcomeId>pm_12903_23_23444872</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9B90BA2-2592-497E-BE18-5514FF8917D3</gtr:id><gtr:title>The cell-cycle state of stem cells determines cell fate propensity.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/406b33d43f90b33b6ebd9839305276a3"><gtr:id>406b33d43f90b33b6ebd9839305276a3</gtr:id><gtr:otherNames>Pauklin S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>doi_12903_013_08_031</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED0A5B96-44B2-4663-9620-EEDB428640A5</gtr:id><gtr:title>The serpinopathies studying serpin polymerization in vivo.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a97c91ca9350b38134a6403aba65587"><gtr:id>5a97c91ca9350b38134a6403aba65587</gtr:id><gtr:otherNames>Irving JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0076-6879</gtr:issn><gtr:outcomeId>TMnp3k7JutB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B752CFE-7F76-42AD-9441-673367662471</gtr:id><gtr:title>Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0396b96262cfc00bc545ab35b73fc343"><gtr:id>0396b96262cfc00bc545ab35b73fc343</gtr:id><gtr:otherNames>Rashid ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>cLPjjRxfMVX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB348E57-7240-42A4-855F-505D4431DEDD</gtr:id><gtr:title>Activin/Nodal signalling in stem cells.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/406b33d43f90b33b6ebd9839305276a3"><gtr:id>406b33d43f90b33b6ebd9839305276a3</gtr:id><gtr:otherNames>Pauklin S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>56b98de35d28b8.03933654</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7231B814-0164-4A24-A7AF-5105DC05A80E</gtr:id><gtr:title>Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c1118ee19c21faa5dab60d89964c47a"><gtr:id>3c1118ee19c21faa5dab60d89964c47a</gtr:id><gtr:otherNames>Touboul T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>tH4T9FC1j6y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C09EC10-CA70-454E-ACE1-43E08860D47B</gtr:id><gtr:title>Emergence of a stage-dependent human liver disease signature with directed differentiation of alpha-1 antitrypsin-deficient iPS cells.</gtr:title><gtr:parentPublicationTitle>Stem cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12d27552a32c6584b335ffca26751039"><gtr:id>12d27552a32c6584b335ffca26751039</gtr:id><gtr:otherNames>Wilson AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-6711</gtr:issn><gtr:outcomeId>56b98e264f4b56.24730128</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDBEC0B6-BB93-4DB0-9BD8-34361C6F1840</gtr:id><gtr:title>Inhibition of activin/nodal signalling is necessary for pancreatic differentiation of human pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6a1c9485baf68585bbd41d4816e0ab7"><gtr:id>a6a1c9485baf68585bbd41d4816e0ab7</gtr:id><gtr:otherNames>Cho CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn><gtr:outcomeId>pm_12903_23_23011350</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA32FB12-DB79-4721-9E01-8E4136609AB4</gtr:id><gtr:title>Pancreatic transcription factors containing protein transduction domains drive mouse embryonic stem cells towards endocrine pancreas.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/646a9a796c02025de09dec09736d0d51"><gtr:id>646a9a796c02025de09dec09736d0d51</gtr:id><gtr:otherNames>Lima MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12903_23_22563503</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F89ACDA-5847-43EE-89E5-C8EF10CD28F5</gtr:id><gtr:title>Status of genomic imprinting in epigenetically distinct pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66eb9cc0e7d5509969cc13671b3df32e"><gtr:id>66eb9cc0e7d5509969cc13671b3df32e</gtr:id><gtr:otherNames>Sun B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_12903_23_22109880</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0C1FFBC-A352-49D4-9223-26A8820DA1BC</gtr:id><gtr:title>Integration-deficient lentivectors: an effective strategy to purify and differentiate human embryonic stem cell-derived hepatic progenitors.</gtr:title><gtr:parentPublicationTitle>BMC biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ff7b7f7e3fc7d6ec885be1b24ed4c2b"><gtr:id>6ff7b7f7e3fc7d6ec885be1b24ed4c2b</gtr:id><gtr:otherNames>Yang G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1741-7007</gtr:issn><gtr:outcomeId>doi_12903_7007_11_86</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DDB7F41-6610-49BE-85F9-0EA24A13341C</gtr:id><gtr:title>Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5d39425d881d3ca4554b5e13958c9ac"><gtr:id>e5d39425d881d3ca4554b5e13958c9ac</gtr:id><gtr:otherNames>Vallier L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>E2608837C1F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60267B98-998B-42E4-BB05-857586845733</gtr:id><gtr:title>Maturation of induced pluripotent stem cell derived hepatocytes by 3D-culture.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69b910fd75a5f4df405412df66812851"><gtr:id>69b910fd75a5f4df405412df66812851</gtr:id><gtr:otherNames>Gieseck RL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12903_23_24466060</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5142B9A7-4731-4CA1-8D3B-90706442E93C</gtr:id><gtr:title>Senescence impairs successful reprogramming to pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70a23e19c84745d189f8858e37a99e99"><gtr:id>70a23e19c84745d189f8858e37a99e99</gtr:id><gtr:otherNames>Banito A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>C10C149ABAB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>214DF6E0-23BC-45B4-A646-924E147952E1</gtr:id><gtr:title>Heps with pep: direct reprogramming into human hepatocytes.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5d39425d881d3ca4554b5e13958c9ac"><gtr:id>e5d39425d881d3ca4554b5e13958c9ac</gtr:id><gtr:otherNames>Vallier L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>pm_12903_23_24607399</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C16BC65A-FDFE-4B94-9119-89371843C6FE</gtr:id><gtr:title>Activin/Nodal signalling maintains pluripotency by controlling Nanog expression.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5d39425d881d3ca4554b5e13958c9ac"><gtr:id>e5d39425d881d3ca4554b5e13958c9ac</gtr:id><gtr:otherNames>Vallier L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>6F6276CECF2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1F7D2E2-A43A-4813-8E66-3E195E6EE30D</gtr:id><gtr:title>Pluripotency factors regulate definitive endoderm specification through eomesodermin.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c95cbddd9d597dde2ca96667a12d4f66"><gtr:id>c95cbddd9d597dde2ca96667a12d4f66</gtr:id><gtr:otherNames>Teo AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>mtK1eHE9ya8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F128932A-30FB-46CB-813D-F21E3DB4291F</gtr:id><gtr:title>Transplantation of expanded fetal intestinal progenitors contributes to colon regeneration after injury.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b898cfb81e4f4b00370f8b5f79a13a3"><gtr:id>6b898cfb81e4f4b00370f8b5f79a13a3</gtr:id><gtr:otherNames>Fordham RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>pm_12903_23_24139758</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>329EAA7E-8F7D-43DD-A0E6-7F2A0A015078</gtr:id><gtr:title>SIP1 mediates cell-fate decisions between neuroectoderm and mesendoderm in human pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac1dd832971703c510fb507db3105ca9"><gtr:id>ac1dd832971703c510fb507db3105ca9</gtr:id><gtr:otherNames>Chng Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>ED2C8FD47D2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0C56156-F44E-4CA0-A966-1E48E55C5E3A</gtr:id><gtr:title>Genomic targets of Brachyury (T) in differentiating mouse embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d2c43929db3bd27a0bde11ff4f84bc9"><gtr:id>1d2c43929db3bd27a0bde11ff4f84bc9</gtr:id><gtr:otherNames>Evans AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12903_23_22479388</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>689CB374-C1A9-430C-AFFC-F3902FD58885</gtr:id><gtr:title>Activin/nodal signaling and pluripotency.</gtr:title><gtr:parentPublicationTitle>Vitamins and hormones</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac1dd832971703c510fb507db3105ca9"><gtr:id>ac1dd832971703c510fb507db3105ca9</gtr:id><gtr:otherNames>Chng Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0083-6729</gtr:issn><gtr:outcomeId>VZeq5SdaNAt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C642D807-974A-4DAC-BA3F-BB7D140AF29F</gtr:id><gtr:title>Investigating the feasibility of scale up and automation of human induced pluripotent stem cells cultured in aggregates in feeder free conditions.</gtr:title><gtr:parentPublicationTitle>Journal of biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e2e5d805263a390d924ccc3b6b5ebf9"><gtr:id>7e2e5d805263a390d924ccc3b6b5ebf9</gtr:id><gtr:otherNames>Soares FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0168-1656</gtr:issn><gtr:outcomeId>pm_12903_23_24440272</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF4860B2-23E4-43DA-AE3F-4EF43E3D7357</gtr:id><gtr:title>Production of hepatocyte-like cells from human pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c216161994663a118ad38f8380f0617"><gtr:id>1c216161994663a118ad38f8380f0617</gtr:id><gtr:otherNames>Hannan NR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>pm_12903_23_23424751</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84361C70-50ED-4ACE-A2A8-FB88156320A1</gtr:id><gtr:title>TEAD and YAP regulate the enhancer network of human embryonic pancreatic progenitors.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f08ad252f7e497f5caf1732a19a0a328"><gtr:id>f08ad252f7e497f5caf1732a19a0a328</gtr:id><gtr:otherNames>Cebola I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>56b98de408b621.88400895</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>195C1D0A-F9C8-444B-AF31-A74E1D304AC1</gtr:id><gtr:title>Nuclear transfer-derived epiblast stem cells are transcriptionally and epigenetically distinguishable from their fertilized-derived counterparts.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b48ca422642a80f8145e05da19470f39"><gtr:id>b48ca422642a80f8145e05da19470f39</gtr:id><gtr:otherNames>Maruotti J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>WRSdfg3G7Dq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C0E4225-AA89-413E-91F9-EC2B031C30FD</gtr:id><gtr:title>Survival and differentiation of adenovirus-generated induced pluripotent stem cells transplanted into the rat striatum.</gtr:title><gtr:parentPublicationTitle>Cell transplantation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40f93453282acd5aac876b6cc648acc2"><gtr:id>40f93453282acd5aac876b6cc648acc2</gtr:id><gtr:otherNames>Fink KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0963-6897</gtr:issn><gtr:outcomeId>pm_12903_23_23879897</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF90A494-C175-4931-B7EF-4A6D2469F4AE</gtr:id><gtr:title>Replacement of the murine common bile duct with a bioengineered conduit incorporating primary human cholangiocyte organoids</gtr:title><gtr:parentPublicationTitle>Journal of Hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc96765a9325d41a43a16a65184cb5ab"><gtr:id>bc96765a9325d41a43a16a65184cb5ab</gtr:id><gtr:otherNames>Sampaziotis F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a6efa6f5cdab2.68563782</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37A5593D-982A-49E9-B841-BAF0C2ABA0FB</gtr:id><gtr:title>Mouse pluripotent stem cells at a glance.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/406b33d43f90b33b6ebd9839305276a3"><gtr:id>406b33d43f90b33b6ebd9839305276a3</gtr:id><gtr:otherNames>Pauklin S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>bQBZNAnSWUL</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D147B46-B911-453D-8E20-992C2F5F4BFD</gtr:id><gtr:title>Human stem cells for craniomaxillofacial reconstruction.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6e14c7529f17755ff421a42cb4da950"><gtr:id>e6e14c7529f17755ff421a42cb4da950</gtr:id><gtr:otherNames>Jalali M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn><gtr:outcomeId>pm_12903_23_24564584</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>228A623D-43B8-42F9-9B2C-909A9D953653</gtr:id><gtr:title>Emerging use of stem cells in regenerative medicine.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c95cbddd9d597dde2ca96667a12d4f66"><gtr:id>c95cbddd9d597dde2ca96667a12d4f66</gtr:id><gtr:otherNames>Teo AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>JtNY9rEsGZQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F2BD4C9-5C5D-4BBD-9A29-DD27610FDDE3</gtr:id><gtr:title>Early cell fate decisions of human embryonic stem cells and mouse epiblast stem cells are controlled by the same signalling pathways.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5d39425d881d3ca4554b5e13958c9ac"><gtr:id>e5d39425d881d3ca4554b5e13958c9ac</gtr:id><gtr:otherNames>Vallier L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>ECEA6984B86</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59584407-0427-4361-804F-F74C1C4B3A8D</gtr:id><gtr:title>Induced pluripotent stem cells--alchemist's tale or clinical reality?</gtr:title><gtr:parentPublicationTitle>Expert reviews in molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0396b96262cfc00bc545ab35b73fc343"><gtr:id>0396b96262cfc00bc545ab35b73fc343</gtr:id><gtr:otherNames>Rashid ST</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1462-3994</gtr:issn><gtr:outcomeId>D9bdbFR9R7e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B35A2C2D-32DC-468F-BAB2-828FF7E0731A</gtr:id><gtr:title>Activin/Nodal signaling controls divergent transcriptional networks in human embryonic stem cells and in endoderm progenitors.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccd67eaa410f1dafd57772937ce7d30c"><gtr:id>ccd67eaa410f1dafd57772937ce7d30c</gtr:id><gtr:otherNames>Brown S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>Whyj6HAVmSs</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701448</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>